Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables Press Trust of India Nov 7, 2022 The drug major also plans to utilise the capital for adding capacities to existing plants, firm up R&D activities and further…
Mankind Pharma forays into critical care, launches division for life-saving injectables EP News Bureau Jan 20, 2022 With the launch, the company aspires to aid the community in leading a healthy life by formulating, developing, commercialising…
AccelTRA Component Case Study: Reducing lead time and optimising cost EP News Bureau Jul 17, 2020 Use of the AccelTRA component platform – including components, extractables data and collaboration with West’s technical experts –…
